Our data suggest that although cancer cell-intrinsic IL-15 can promote metastasis, high expression of IL-15 in tumor cells increases the amount of IL-15 in the tumor microenvironment and enhances the efficacy of anti-PD-L1 immunotherapy. This evidence concerns the gene IL15 and cancer.